脊髓损伤患者的硬膜外和背根刺激
2026年6月18日 更新者:Peter J. Grahn, Ph.D.
脊髓损伤患者硬膜外和背根刺激的初步研究
一项比较硬膜外刺激和背根神经节刺激的电生理活动的研究,以及在 10 次康复疗程中量化这两种刺激的运动表现变化。
研究概览
详细说明
本研究旨在扩大对脊柱电刺激如何实现功能的理解,特别是脊髓损伤后脊柱电刺激作用的病理生理机制,并解决人类脊柱电刺激产生的脊髓感觉运动网络输入和输出的知识差距科学论文集。
研究类型
介入性
注册 (实际的)
22
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Minnesota
-
Rochester、Minnesota、美国、55905
- Mayo Clinic
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
22年 及以上 (成人、年长者)
接受健康志愿者
不
描述
纳入标准:
- 位于第十胸椎或以上的外伤导致的脊髓损伤
- 美国脊髓损伤协会 A、B、C 或 D 分级量表
- SCI 水平以下的完整脊髓反射
- SCI 必须至少在入学前 1 年发生
- 至少22岁
- 如果是女性,必须愿意在参与研究期间使用医学上可接受的避孕方法
排除标准:
- 目前是监狱犯人,或等待审判,与犯罪活动有关
- 试验登记筛选时怀孕
- 活动性、未经治疗的尿路感染
- 未愈合的褥疮
- 未愈合的骨折
- 可能阻碍脊柱电极经皮植入的脊柱异常
- 未经治疗的精神障碍的临床诊断
- 阻碍典型运动范围的关节挛缩
- 不兼容 MRI 的植入式医疗设备
- 正在进行或计划进行透热疗法
- 积极参与介入临床试验
- 临床诊断为心肺疾病的病史,例如严重的体位性低血压,这可能会妨碍参与康复活动,例如身体姿势的改变,例如仰卧-坐-站活动、长时间站立或踏步
- 频繁和/或严重的自主神经反射异常病史
- 癫痫病史
- 根据研究小组的评估,任何疾病或病症将损害患者遵守方案的能力、患者安全或本研究期间收集的数据的有效性
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:基础科学
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:经皮 ES 和 DRS
硬膜外刺激 (ES) 和背根刺激 (DRS) 将在康复期间通过经皮植入的电极进行。
所有植入的电极将在参与试验结束时移除。
ES 和 DRS 的影响将通过结果测量中描述的电生理学和生物力学指标进行记录。
|
用于背根神经节神经刺激的 Abbott 经皮试验导线(型号 MN10350) 用于硬膜外神经刺激的 Abbott 经皮试验导线(型号 3086) 用于硬膜外和背根神经节神经刺激的雅培临床医生编程器(型号 3874) Ripple Neuromed Nomad 神经刺激系统 |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Electromyography
大体时间:Assessed at Day 1 (beginning of intervention) and Day 10 (end of intervention).
|
Percent change in EMG voltage from beginning to end of intervention, recorded from the rectus femoris, during epidural and dorsal root spinal stimulation.
|
Assessed at Day 1 (beginning of intervention) and Day 10 (end of intervention).
|
|
Foot Pressure
大体时间:Assessed at Day 10 (end of intervention).
|
Measurements of foot pressure from shoe-insole sensors during no-stimulation bilaterally assisted standing and unassisted standing with stimulation.
|
Assessed at Day 10 (end of intervention).
|
|
Somatosensory Evoked Potentials
大体时间:Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
Change from baseline to end of study, in amplitude of evoked potentials recorded from sensory cortex using skin surface electrodes during electrical stimulation of the right and left tibial nerve.
|
Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
|
Transcranial Magnetic Stimulation Motor Evoked Potentials
大体时间:Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
Change in intensity of stimulation, reported as percentage (0% to 100%) of maximum system output, required to elicit motor-evoked potentials below the level of injury.
|
Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
|
American Spinal Injury Association Grading Scale
大体时间:Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
Severity of spinal cord injury impairment will be assessed at baseline and end of study to examine changes in impairment that may be associated with the intervention.
|
Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
|
Spasticity
大体时间:Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
Change in measurements of spasticity using the Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET).
Answers to qualitative questions are rated from -3 to +3, with a higher positive number indicating more helpful symptoms, and a lower negative number indicating more problematic symptoms.
Questions may also be answered as not applicable (N/A), which do not generate a score.
Scores are totaled for a score which categorizes the overall positive or negative impact of a subject's spasticity symptoms.
Total score can range from -105 (negative impact) to +105 (positive impact), and the score is averaged by total positive or negative score divided by the number of applicable answers.
|
Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
|
Modified Functional Reach Test
大体时间:Assessed at Day 10 (end of intervention).
|
On Day 10 (end of intervention), trunk balance was assessed with and without stimulation during attempts to reach forward using the modified functional reach test.
|
Assessed at Day 10 (end of intervention).
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Patient-reported Bowel Function
大体时间:Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
Measurement of change in bowel function using the Neurogenic Bowel Dysfunction Score.
Answers to qualitative questions are rated from 0 to 5, with a higher number indicating more problematic symptoms, and totaled for a score which categorizes severity of neurogenic bowel symptoms.
The total score ranges between 0 and 44 points.
A higher total score indicates more severe bowel symptoms.
|
Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
|
Patient-reported Bladder Function
大体时间:Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
Measurement of change in bladder function using the Neurogenic Bladder Symptom Score.
Answers to qualitative questions are rated from 0 to 5, with a higher number indicating more problematic symptoms, and totaled for a score which categorizes severity of neurogenic bladder symptoms.
The total score can range from 0 (no symptoms at all) to 74 (maximum symptoms).
|
Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
|
Male Patient-reported Sexual Function (SHIM)
大体时间:Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
Measurement of change in erectile dysfunction using the Sexual Health Inventory for Men (SHIM).
Answers to qualitative questions are rated from 0 to 5, with a higher number indicating better erectile function, and totaled for a score which categorizes severity of erectile dysfunction.
Total score can range from 1 to 25, with a lower number indicating more severe erectile dysfunction.
|
Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
|
Male Patient-reported Sexual Function (IEF)
大体时间:Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
Measurement of change in erectile dysfunction using the International Index for Erectile Function (IIEF).
Answers to qualitative questions are rated from 0 to 5, with a higher number indicating better erectile function, and totaled for a score which categorizes severity of erectile dysfunction.
Total scores range from 5 to 25, with a lower score indicating more severe erectile dysfunction.
|
Captured during screening assessments and at end of study (i.e., before day 1 and after day 10 of intervention).
|
|
Neurostimulation User Experience
大体时间:Assessed at end of study ( after day 10 of intervention).
|
Rating of the subject's perception of individual aspects of spinal stimulation using the User Experience Questionnaire (UEQ), a survey including 26 descriptive terms and their antonyms.
A scoring scale ranging from 1 to 7 determines how closely the subject feels the term or its antonym applies to the intervention, with lower numbers indicating agreement with the term, and higher numbers indicating agreement with the antonym.
The terms and antonyms describe a positive and negative perception of each item.
|
Assessed at end of study ( after day 10 of intervention).
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Peter J. Grahn, Ph.D.、Mayo Clinic
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2021年9月24日
初级完成 (实际的)
2025年3月19日
研究完成 (实际的)
2025年3月19日
研究注册日期
首次提交
2020年12月18日
首先提交符合 QC 标准的
2021年2月2日
首次发布 (实际的)
2021年2月3日
研究记录更新
最后更新发布 (实际的)
2026年7月16日
上次提交的符合 QC 标准的更新
2026年6月18日
最后验证
2026年6月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.